Related Experiment Video

Updated: May 12, 2026

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model
09:00

Comparative Strategies for Ubiquitination Detection in Mammalian Cell Lysates Using SMAD2/SMURF2 as a Model

Published on: April 17, 2026

Reduced expression of SM22 is correlated with low autophagy activity in human colorectal cancer

Xiao-Li Xie1, Ya-Bin Liu, Yue-Ping Liu

  • 1Department of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Hebei Medical University, Shijiazhuang 050017, PR China.

Pathology, Research and Practice
|March 30, 2013
PubMed

Insights

Colorectal cancer (CRC) shows reduced SM22 protein levels, correlating with decreased autophagy. This suggests SM22 disruption may drive CRC tumorigenesis by suppressing autophagy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Colorectal cancer (CRC) is a significant global health concern with high mortality.
  • Autophagy deregulation is increasingly recognized in human cancer development.
  • SM22 is identified as a potential tumor suppressor protein.

Purpose of the Study:

  • To investigate the relationship between SM22 expression and autophagy activity in colorectal cancer.
  • To explore the correlation between SM22 levels and clinical characteristics of CRC patients.

Main Methods:

  • Western blot and immunohistochemical staining were used to detect SM22 and p62 (autophagy biomarker) expression.
  • Paired tumor and adjacent non-tumor tissues from 43 CRC patients were analyzed.
  • Expression analysis was also performed in human CRC cell lines.

Main Results:

  • SM22 expression was significantly decreased in 81.4% of CRC tissues.
  • p62 expression was elevated in 79.1% of CRC tissues, indicating increased autophagy activity.
  • A significant negative correlation was found between SM22 and p62 expression in CRC tissues and cell lines (p=0.004).

Conclusions:

  • Autophagy activity appears suppressed in human colorectal cancer, linked to reduced SM22 expression.
  • SM22 disruption may contribute to CRC tumorigenesis.
  • SM22 may function as a positive regulator of autophagy in the context of CRC.

More Related Videos

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence08:07

Evaluating Autophagy Levels in Two Different Pancreatic Cell Models Using LC3 Immunofluorescence

Published on: April 28, 2023

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry11:39

Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry

Published on: July 21, 2017

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...